Retracted
This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
PMC · DOI:10.3389/fonc.2024.1383410·February 20, 2024
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Research Studies · Glioma Diagnosis and Treatment · Neuroblastoma Research and Treatments